CIRSE's flagship journal
CardioVascular and Interventional Radiology (CVIR) is an official journal of
the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Founded in 1978 by Professors Herbert L. Abrams and Eberhard Zeitler,
CVIR is the longest-running journal in the field of vascular and interventional radiology.
CIRSE Members have unlimited online access to all CVIR articles. To access the full text articles, log in with the credentials for myCIRSE.
news
Visual abstracts
Optimize your article with the new feature in CVIR! Submit a visual abstract of your paper in addition to the textual abstract, to highlight your research and findings. All article types are eligible, with the exception of editorials, letters to the editor and commentaries. Click here to download the template.
New! SOP on Oesophageal and Gastroduodenal Stenting
This SOP document provides up-to-date recommendations for the safe performance of upper gastrointestinal stent placement.
Many thanks to Athanasios Diamantopoulos and the entire writing group for creating this important document! It is published open access. Enjoy it and pass it on to your colleagues!
Editor's Choice: May 2023
Low dose is equally good! Outcomes from data extracted from the LANDMARK registry on 477 patients did not reveal any difference in clinical outcomes at two years between low and high dose paclitaxel coated balloons for the treatment of femoropopliteal lesions. However, no data on mortality and major amputation was presented.
Editor's Choice May 2023
Read this interesting commentary regarding the contradictory data from the comparison between high and low dose paclitaxel coated balloons.
Special section on radioembolisation
CVIR's latest special section was curated by guest editors Professors Laura Crocetti and Thierry de Baère.
Professors Crocetti and de Baère commissioned nine articles, which they say in their introduction editorial "cover the most recent knowledge and scientific evidence about radioembolization
technique, patient selection and clinical outcomes."
Medical devices in Europe
CIRSE fully supports a new regulatory framework for medical devices that ensures that only safe and effective devices enter or remain on the European market.
However, considering potential risks linked to the legal transition in progress, the society urges all stakeholders to take actions that will allow the avoidance of negative consequences for patients and ensure the continuous availability of devices.
Read the editorial free of cost here!
Guidelines for reporting on studies
Are you about to submit your paper to CVIR?
Click here to find out which biological/biomedical reporting checklists are mandatory when submitting to CVIR.
Direct transfer of good papers from CVIR to CVIR Endovascular!
CIRSE has a journal family!
Good papers submitted to CVIR and not accepted due to CVIR's limited page budget will be offered transfer to CVIR Endovascular for consideration.
the CIRSE journal family
